Contineum Therapeutics (CTNM) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

CTNM Contineum Therapeutics

Watchlist

14.650
+0.180+1.24%

Close Dec 31 16:00 ET

13.930
-0.720-4.91%

Pre 06:50 ET

377.64MMarket Cap-13.05P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Top Premarket Decliners
MT NewswiresDec 27, 2024 07:40 ET
Contineum Starts Patient Dosing in Positron Emission Tomography Trial
MT NewswiresDec 16, 2024 17:58 ET
Adobe, Keros Therapeutics, Lovesac And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
BenzingaDec 12, 2024 08:54 ET
Why DBV Technologies Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
BenzingaDec 12, 2024 05:41 ET
Contineum Therapeutics to Attend the 7th Annual Evercore HealthCONx Conference
BusinesswireNov 25, 2024 08:05 ET
Express News | Contineum Therapeutics Inc - Expects $213.9 Mln Cash to Fund Operations Through 2027
ReutersNov 18, 2024 08:05 ET

Comments

Pinchie McPincher

Apr 19, 2024 03:23

$Contineum Therapeutics (CTNM.US)$what am i missing?

Jaguar8

Apr 4, 2024 22:56

$Contineum Therapeutics (CTNM.US)$
NEWS
Contineum Therapeutics, Inc. announces pricing of IPO, offering 6,875,000 shares of Class A common stock at $16.00 per share, expecting gross proceeds of $110.0 million. Shares to trade on Nasdaq under symbol 'CTNM'.